- $21.01bn
- $23.01bn
- $2.10bn
- 74
- 14
- 85
- 58
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,256 | 1,458 | 1,807 | 1,933 | 2,097 |
Cost of Revenue | |||||
Gross Profit | 930 | 1,124 | 1,436 | 1,547 | 1,656 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,193 | 1,248 | 1,426 | 1,486 | 1,639 |
Operating Profit | 63 | 211 | 381 | 447 | 458 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 20.3 | 135 | 392 | 397 | 333 |
Provision for Income Taxes | |||||
Net Income After Taxes | -27.5 | 131 | 477 | 313 | 246 |
Net Income Before Extraordinary Items | |||||
Net Income | -27.5 | 131 | 477 | 313 | 246 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -27.5 | 131 | 477 | 313 | 246 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.066 | 1.47 | 4.12 | 2.98 | 2.17 |